Bacterial Flora Play Important Roles in Acute Dextran Sulphate Sodium-Induced Colitis But Are Not Involved in Gal-3 Dependent Modulation of Colon Inflammation

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3:521-533.10.1038/nri1132Search in Google Scholar

2. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008; 43:1-17.10.1007/s00535-007-2111-3Open DOISearch in Google Scholar

3. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98:694-702.10.1016/0016-5085(90)90290-HOpen DOISearch in Google Scholar

4. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012; 2012:718617.10.1155/2012/718617336136522665990Search in Google Scholar

5. Volarevic V, Milovanovic M, Ljujic B, et al. Galectin-3 Deficiency Prevents Concanavalin A- Induced Hepatitis in Mice. Hepatology 2012; 55:1954-1964.10.1002/hep.2554222213244Open DOISearch in Google Scholar

6. Jiang H-R, Al Rasebi Z, Mensah-Brown E, et al. Galectin- 3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. J Immunol 2009; 182:1167-1173.10.4049/jimmunol.182.2.116719124760Search in Google Scholar

7. Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, Mitrovic S, Milosavljevic M, Besra G, Trajkovic V, Arsenijevic N, Lukic ML, Volarevic V. Galectin-3 Plays an Important Proinflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages. J Crohns Colitis. 2016; 10: 593-606.10.1093/ecco-jcc/jjw013495745826786981Search in Google Scholar

8. Radosavljevic G, Jovanovic I, Majstorovic I, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis 2011; 28:451-462.10.1007/s10585-011-9383-y21442355Search in Google Scholar

9. Radosavljevic G, Volarevic V, Jovanovic I, et al. The roles of Galectin-3 in autoimmunity and tumor progression. Immunol Res 2012; 52:100-110.10.1007/s12026-012-8286-622418727Search in Google Scholar

10. Arsenijevic A, Milovanovic M, Milovanovic J, Stojanovic B, Zdravkovic N, Leung PS, Liu FT, Gershwin ME, Lukic ML. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Sci Rep. 2016; 6:23348.10.1038/srep23348480040026996208Search in Google Scholar

11. Pejnovic N, Pantic J, Jovanovic I, et al. Galectin-3 Deficiency Accelerates High-Fat Diet Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets. Diabetes 2013; 62:1932-1944.10.2337/db12-0222Open DOISearch in Google Scholar

12. Frol’ova L, Smetana K Jr, Borovska D, et al. Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 2009; 58:503-512.10.1007/s00011-009-0016-8Search in Google Scholar

13. Muller S, Schaffer T, Flogerzi B, et al. Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis 2006; 12:588-597.10.1097/01.MIB.0000225341.37226.7cOpen DOISearch in Google Scholar

14. Brazowski E, Dotan I, Tulchinsky H, et al. Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA). Pathol Res Pract 2009; 205:551-558.10.1016/j.prp.2009.02.001Search in Google Scholar

15. Hsu DK, Yang RY, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000; 156:1073-1083.10.1016/S0002-9440(10)64975-9Search in Google Scholar

16. Murthy S, Cooper H, Shim H, et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine. Dig Dis Sci 1993; 38:1722-1734. 10.1007/BF01303184Open DOISearch in Google Scholar

17. Whittem CG, Williams AD, Williams CS. Murine Colitis Modeling using Dextran Sulfate Sodium. J Vis Exp 2010; 35:1652.10.3791/1652Search in Google Scholar

18. Obermeier F, Kojouharoff G, Hans W, et al. Interferon- gamma (IFNgamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116:238-245.10.1046/j.1365-2249.1999.00878.xSearch in Google Scholar

19. Hans W, Scholmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000; 12:267-273.10.1097/00042737-200012030-00002Open DOISearch in Google Scholar

20. Hall GS, Woods GL. Medical bacteriology. In: McPherson RA, Pincus MR, eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. Philadelphia, PA: Elsevier; 2017: chap 58.Search in Google Scholar

21. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993; 75:253-261.10.1016/0092-8674(93)80067-OOpen DOISearch in Google Scholar

22. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75:263-274.10.1016/0092-8674(93)80068-PSearch in Google Scholar

23. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66:5224-5231.10.1128/IAI.66.11.5224-5231.19981086529784526Search in Google Scholar

24. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121:1320-1328.10.1053/gast.2001.2969411729111Search in Google Scholar

25. Bodger K, Halfvarson J, Dodson AR, et al. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 2006; 55:973- 977.10.1136/gut.2005.086413185633816461776Open DOISearch in Google Scholar

26. Hsu DK, Chernyavsky AI, Chen HY, et al. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol 2009; 129:573-583.10.1038/jid.2008.276264523318843294Search in Google Scholar

27. Liu FT, Hsu DK. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect 2007; 20:455-460.10.1358/dnp.2007.20.7.114962817992268Open DOISearch in Google Scholar

28. Simovic Markovic B, Nikolic A, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V. Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem Cells Int. 2016; 2016:2640746.10.1155/2016/2640746473631927057168Search in Google Scholar

29. Bodger K, Halfvarson J, Dodson AR, et al. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 2006; 55:973- 977.10.1136/gut.2005.086413Open DOISearch in Google Scholar

30. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56:669-675.10.1136/gut.2006.099796194216017028128Open DOISearch in Google Scholar

31. Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol. 1998; 51:657-661.10.1136/jcp.51.9.6575009019930068Open DOISearch in Google Scholar

32. Araki Y, Mukaisho K, Sugihara H, Fujiyama Y, Hattori T. Proteus mirabilis sp. intestinal microflora grow in a dextran sulfate sodium-rich environment. Int J Mol Med. 2010; 25:203-208.10.3892/ijmm_00000331Search in Google Scholar

33. Videla S, Vilaseca J, Guarner F, Salas A, Treserra F, Crespo E, Antolin M, Malagelada JR. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut. 1994; 35:1090-1097.10.1136/gut.35.8.109013750617926912Open DOISearch in Google Scholar

34. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978; 74:521-526.10.1016/0016-5085(78)90289-5Search in Google Scholar